🇺🇸 SOMATROGON in United States

57 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Injection Site Pain — 19 reports (33.33%)
  2. Incorrect Dose Administered By Device — 8 reports (14.04%)
  3. Device Mechanical Issue — 6 reports (10.53%)
  4. Device Delivery System Issue — 4 reports (7.02%)
  5. Drug Dose Omission By Device — 4 reports (7.02%)
  6. Lipodystrophy Acquired — 4 reports (7.02%)
  7. Device Defective — 3 reports (5.26%)
  8. Device Leakage — 3 reports (5.26%)
  9. Device Use Error — 3 reports (5.26%)
  10. Injection Site Erythema — 3 reports (5.26%)

Source database →

SOMATROGON in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is SOMATROGON approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for SOMATROGON in United States?

Marketing authorisation holder not available in our data.